ArticleWorld journal of clinical cases2024

Lenvatinib combined with sintilimab plus transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma.

Sha-Sha Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.